当前位置:首页>产品中心>单抗/多抗>Anti-galactose-deficient IgA1 Recombinant Antibody|抗半乳糖缺陷型IgA1重组抗体(靶标:半乳糖缺陷型IgA1)

Anti-galactose-deficient IgA1 Recombinant Antibody|抗半乳糖缺陷型IgA1重组抗体(靶标:半乳糖缺陷型IgA1)

  • 货号:RB9THV621013
  • 价格:面议
  • 点击:352
   一键复制产品信息 复制成功!

产品介绍

产品参数

形态Liquid
宿主种属Rat
克隆性Monoclonal
抗体亚型IgG2b, kappa
纯度>95% as determined by SDS-PAGE.
纯化方式Protein A/G purified from cell culture supernatant.
内毒素水平Please contact with the lab for this information.
应用ELISA, IF, IHC
种属反应性Homo sapiens (Human)
靶标galactose-deficient IgA1, Gd-IgA1, IGHA1, Ig alpha-1 chain C region, Ig alpha-1 chain C region BUR, Ig alpha-1 chain C region TRO, Immunoglobulin heavy constant alpha 1
储存缓冲液0.01M PBS pH 7.4
稳定性和储存Use a manual defrost freezer and avoid repeated freeze thaw cycles. Store at 2 to 8°C for frequent use. Store at -20 to -80°C for twelve months from the date of receipt.
重构方法Reconstitute in sterile water for a stock solution. A copy of datasheet will be provided with the products, please refer to it for details.
登录号P01876
背景信息

Immunoglobulin heavy constant alpha 1 (Gd-IgA1) is a ~42 kDa protein. Constant region of immunoglobulin heavy chains. Immunoglobulins, also known as antibodies, are membrane-bound or secreted glycoproteins produced by B lymphocytes. In the recognition phase of humoral immunity, the membrane-bound immunoglobulins serve as receptors which, upon binding of a specific antigen, trigger the clonal expansion and differentiation of B lymphocytes into immunoglobulins-secreting plasma cells. Secreted immunoglobulins mediate the effector phase of humoral immunity, which results in the elimination of bound antigens. The antigen binding site is formed by the variable domain of one heavy chain, together with that of its associated light chain.

1. Schroeder, HW. et al. (2010) The Journal of allergy and clinical immunology 125, S41-52. PMID: 20176268
2. McHeyzer-Williams, M. et al. (2011) Nature reviews. Immunology 12, 24-34. PMID: 22158414
3. Teng, G. et al. (2007) Annual review of genetics 41, 107-20. PMID: 17576170
4. Kerr, MA. (1990) The Biochemical journal 271, 285-96. PMID: 2241915
备注For research use only
【仅供科学研究使用】

相关产品:
产品名称 点击数
Anti-Phosphatidylserine Recombinant Antibody|抗磷脂酰丝氨酸重组抗体(靶标:磷脂酰丝氨酸) 372
Anti-Phosphatidylserine Recombinant Antibody|抗磷脂酰丝氨酸重组抗体(靶标:磷脂酰丝氨酸) 369
Anti-ADI-1942 Recombinant Antibody |抗ADI-1942重组抗体(靶标:ADI-1942抗体) 451
Anti-ADI-1942 Recombinant Antibody |抗ADI-1942重组抗体(靶标:ADI-1942抗体) 258
Anti-CCHFV RdRp Recombinant Antibody |抗CCHFV RdRp重组抗体(靶标:克里米亚-刚果出血热病毒RNA依赖性RNA聚合酶) 503
Anti-KASV RdRp Recombinant Antibody |抗KASV RdRp重组抗体(靶标:卡萨马病毒RNA依赖性RNA聚合酶) 333
Anti-CD18/ITGB2 Recombinant Antibody, FITC|抗CD18/ITGB2重组抗体, FITC标记(靶标:整合素β2亚基/CD18(FITC标记)) 536
Anti-CD18/ITGB2 Recombinant Antibody, PE|抗CD18/ITGB2重组抗体, PE标记(靶标:整合素β2亚基/CD18(PE标记)) 312
Anti-CD18/ITGB2 Recombinant Antibody, APC|抗CD18/ITGB2重组抗体, APC标记(靶标:整合素β2亚基/CD18(APC标记)) 311
Anti-CD18/ITGB2 Recombinant Antibody, PerCP|抗CD18/ITGB2重组抗体, PerCP标记(靶标:整合素β2亚基/CD18(PerCP标记)) 532
Anti-CD18/ITGB2 Recombinant Antibody|抗CD18/ITGB2重组抗体(靶标:整合素β2亚基/CD18) 582
Anti-FMDV (SAT-1) VP1 Polyclonal Antibody|抗FMDV(SAT-1)VP1多克隆抗体(靶标:口蹄疫病毒SAT-1型衣壳蛋白VP1) 566
Anti-Human HBB Polyclonal Antibody|抗人HBB多克隆抗体(靶标:人血红蛋白β亚基) 280
Anti-Mouse APOD Polyclonal Antibody|抗小鼠APOD多克隆抗体(靶标:小鼠载脂蛋白D) 558
Anti-Cosibelimab Polyclonal Antibody|抗Cosibelimab多克隆抗体(靶标:Cosibelimab多克隆抗体) 452
Anti-NKG2A/CD159a/KLRC1 Recombinant Antibody|抗NKG2A/CD159a/KLRC1重组抗体(靶标:杀伤细胞凝集素样受体C1/NKG2A/CD159a) 532
Anti-Human CD340/ERBB2/HER2 Recombinant Antibody|抗人CD340/ERBB2/HER2重组抗体(靶标:人受体酪氨酸蛋白激酶ERBB2/HER2/CD340) 507
Anti-FMDV (SAT-1) VP2 Polyclonal Antibody|抗FMDV(SAT-1)VP2多克隆抗体(靶标:口蹄疫病毒SAT-1型衣壳蛋白VP2) 523
Anti-FMDV (SAT-1) VP3 Polyclonal Antibody|抗FMDV(SAT-1)VP3多克隆抗体(靶标:口蹄疫病毒SAT-1型衣壳蛋白VP3) 267
Anti-FMDV (SAT-1) VP4 Polyclonal Antibody|抗FMDV(SAT-1)VP4多克隆抗体(靶标:口蹄疫病毒SAT-1型衣壳蛋白VP4) 255
总计 33037 个记录,共 1652 页,当前第 1640 页 | 第一页 上一页 下一页 最末页
在线客服
  • 销售热线:
  • 15898894496(同微信)
  • 我要留言
  • 周一至周五每天9:00-17:00